Drug Type Small molecule drug |
Synonyms KMI-420 |
Target |
Action inhibitors |
Mechanism BACE1 inhibitors(Beta-secretase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H44N10O8 |
InChIKeyFOEYBHHGUJYFBZ-WBAQKLHDSA-N |
CAS Registry753030-11-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | Japan | 03 Jan 2005 |